These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

668 related items for PubMed ID: 10716912

  • 21. Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogene.
    Castelli C, Sensi M, Lupetti R, Mortarini R, Panceri P, Anichini A, Parmiani G.
    Cancer Res; 1994 Sep 01; 54(17):4785-90. PubMed ID: 8062279
    [Abstract] [Full Text] [Related]

  • 22. Peripheral T-cell lymphoma with follicular T-cell markers.
    Rodríguez-Pinilla SM, Atienza L, Murillo C, Pérez-Rodríguez A, Montes-Moreno S, Roncador G, Pérez-Seoane C, Domínguez P, Camacho FI, Piris MA.
    Am J Surg Pathol; 2008 Dec 01; 32(12):1787-99. PubMed ID: 18779728
    [Abstract] [Full Text] [Related]

  • 23. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF, Mora C, Gómez M, Muros M, López-Aguilar C, García J.
    Nephrol Dial Transplant; 2008 Mar 01; 23(3):919-26. PubMed ID: 17911088
    [Abstract] [Full Text] [Related]

  • 24. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
    Petit B, Leroy K, Kanavaros P, Boulland ML, Druet-Cabanac M, Haioun C, Bordessoule D, Gaulard P.
    Hum Pathol; 2001 Feb 01; 32(2):196-204. PubMed ID: 11230707
    [Abstract] [Full Text] [Related]

  • 25. Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1 beta, IL-4, and IL-6 in vitro.
    Dett CA, Gatanaga M, Ininns EK, Cappuccini F, Yamamoto RS, Granger GA, Gatanaga T.
    J Immunol; 1991 Mar 01; 146(5):1522-6. PubMed ID: 1847164
    [Abstract] [Full Text] [Related]

  • 26. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
    Niiya M, Niiya K, Kiguchi T, Shibakura M, Asaumi N, Shinagawa K, Ishimaru F, Kiura K, Ikeda K, Ueoka H, Tanimoto M.
    Cancer Chemother Pharmacol; 2003 Nov 01; 52(5):391-8. PubMed ID: 12908082
    [Abstract] [Full Text] [Related]

  • 27. Peripheral T cell lymphoma following angioimmunoblastic lymphadenopathy.
    Brice P, Calvo F, d'Agay MF, Gisselbrecht C, Valensi F, Trédaniel J, Boiron M, Flandrin G.
    Nouv Rev Fr Hematol (1978); 1987 Nov 01; 29(6):371-7. PubMed ID: 3502546
    [Abstract] [Full Text] [Related]

  • 28. Real-time polymerase chain reaction determination of cytokine mRNA expression profiles in Hodgkin's lymphoma.
    Malec M, Söderqvist M, Sirsjö A, MacNamara B, Lewin N, Sjöberg J, Björkholm M, Porwit-MacDonald A.
    Haematologica; 2004 Jun 01; 89(6):679-85. PubMed ID: 15194535
    [Abstract] [Full Text] [Related]

  • 29. Role of tumor necrosis factor-alpha and its receptors in human benign breast lesions and tumors (in situ and infiltrative).
    García-Tuñón I, Ricote M, Ruiz A, Fraile B, Paniagua R, Royuela M.
    Cancer Sci; 2006 Oct 01; 97(10):1044-9. PubMed ID: 16984377
    [Abstract] [Full Text] [Related]

  • 30. [Angioblastic lymphadenopathy--its course and prognosis].
    Mihaljević B, Jancić-Nedeljkov R, Janković S, Milivojević G, Cemerikić-Martinović V, Jovanović V, Colović M, Petrović M.
    Srp Arh Celok Lek; 1999 Oct 01; 127(11-12):376-82. PubMed ID: 10686819
    [Abstract] [Full Text] [Related]

  • 31. Modified antisense oligonucleotides directed against tumor necrosis factor receptor type I inhibit tumor necrosis factor alpha-mediated functions.
    Ojwang JO, Mustain SD, Marshall HB, Rao TS, Chaudhary N, Walker DA, Hogan ME, Akiyama T, Revankar GR, Peyman A, Uhlmann E, Rando RF.
    Biochemistry; 1997 May 20; 36(20):6033-45. PubMed ID: 9166774
    [Abstract] [Full Text] [Related]

  • 32. Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia.
    Catalano MG, Fortunati N, Arena K, Costelli P, Aragno M, Danni O, Boccuzzi G.
    Int J Oncol; 2003 Aug 20; 23(2):429-36. PubMed ID: 12851692
    [Abstract] [Full Text] [Related]

  • 33. Role of tumour necrosis factor-alpha in dendritic cell-mediated primary mixed leucocyte reactions.
    McKenzie JL, Calder VL, Starling GC, Hart DN.
    Bone Marrow Transplant; 1995 Feb 20; 15(2):163-71. PubMed ID: 7773205
    [Abstract] [Full Text] [Related]

  • 34. The IL-6 gene expression by leukemic cells from acute lymphoblastic leukemia common and T type and modulation of IL-6 production by TNF.
    Pituch-Noworolska A, Wieckiewicz J, Gawlicka M, Wołoszyn M, Ruggiero I, Zembala M.
    Haematologia (Budap); 1998 Feb 20; 29(2):101-14. PubMed ID: 9728802
    [Abstract] [Full Text] [Related]

  • 35. Characterization of cytokine responses to retinal detachment in rats.
    Nakazawa T, Matsubara A, Noda K, Hisatomi T, She H, Skondra D, Miyahara S, Sobrin L, Thomas KL, Chen DF, Grosskreutz CL, Hafezi-Moghadam A, Miller JW.
    Mol Vis; 2006 Aug 07; 12():867-78. PubMed ID: 16917487
    [Abstract] [Full Text] [Related]

  • 36. Regulation of TCR-mediated T cell activation by TNF-RII.
    Aspalter RM, Eibl MM, Wolf HM.
    J Leukoc Biol; 2003 Oct 07; 74(4):572-82. PubMed ID: 12960285
    [Abstract] [Full Text] [Related]

  • 37. Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha.
    Ryffel B, Brockhaus M, Dürmüller U, Gudat F.
    Am J Pathol; 1991 Jul 07; 139(1):7-15. PubMed ID: 1649557
    [Abstract] [Full Text] [Related]

  • 38. Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction.
    Yang L, Aozasa K, Oshimi K, Takada K.
    Cancer Res; 2004 Aug 01; 64(15):5332-7. PubMed ID: 15289339
    [Abstract] [Full Text] [Related]

  • 39. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
    Boldrini L, Calcinai A, Samaritani E, Pistolesi F, Mussi A, Lucchi M, Angeletti CA, Basolo F, Fontanini G.
    Br J Cancer; 2000 Aug 01; 83(4):480-6. PubMed ID: 10945495
    [Abstract] [Full Text] [Related]

  • 40. Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy.
    Smith JL, Hodges E, Quin CT, McCarthy KP, Wright DH.
    Am J Pathol; 2000 Feb 01; 156(2):661-9. PubMed ID: 10666395
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.